{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:35:03Z","timestamp":1762954503967},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1053\/j.seminoncol.2004.12.008","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T13:58:14Z","timestamp":1131026294000},"page":"25-28","source":"Crossref","is-referenced-by-count":21,"special_numbering":"S18","title":["A phase II study to assess the efficacy of amifostine for submandibular\/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing"],"prefix":"10.1053","volume":"31","author":[{"given":"David I.","family":"Rosenthal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randal S.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avraham","family":"Eisbruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2004.12.008_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0347(199901)21:1<1::AID-HED1>3.0.CO;2-4","article-title":"Quality of life and oral function following radiotherapy for head and neck cancer","volume":"21","author":"Epstein","year":"1999","journal-title":"Head Neck"},{"key":"10.1053\/j.seminoncol.2004.12.008_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0360-3016(93)90143-J","article-title":"Major salivary gland function in patients with radiation-induced xerostomia","volume":"25","author":"Valdez","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.seminoncol.2004.12.008_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/(SICI)1097-0347(199705)19:3<169::AID-HED1>3.0.CO;2-0","article-title":"Detailed quality of life assessment in patients treated with primary radiotherapy for cancer of the base of tongue","volume":"19","author":"Harrison","year":"1997","journal-title":"Head Neck"},{"key":"10.1053\/j.seminoncol.2004.12.008_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0167-8140(03)00023-9","article-title":"Prevention of radiation induced xerostomia by surgical transfer of submandibular gland into the submental space","volume":"66","author":"Jha","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1053\/j.seminoncol.2004.12.008_bib5","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1200\/JCO.2000.18.19.3339","article-title":"Phase III randomized trial of amifostine as a radioprotector in head and neck cancer","volume":"18","author":"Brizel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2004.12.008_bib6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/BF00368886","article-title":"Oral and dental management of the cancer patient; patient","volume":"3","author":"Chambers","year":"1995","journal-title":"Support Care Cancer"},{"key":"10.1053\/j.seminoncol.2004.12.008_bib7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1177\/00220345870660S207","article-title":"Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man","volume":"66","author":"Dawes","year":"1987","journal-title":"J Dent Res"},{"key":"10.1053\/j.seminoncol.2004.12.008_bib8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0360-3016(01)01512-7","article-title":"Xerostomia and its predictors following parotid sparing irradiation of head and neck","volume":"50","author":"Eisbruch","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.seminoncol.2004.12.008_bib9","series-title":"Cancer Medicine","first-page":"3255","article-title":"Oral complications","author":"Sonis","year":"1997"},{"key":"10.1053\/j.seminoncol.2004.12.008_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0360-3016(01)01981-2","article-title":"A Phase III study on the concurrent use of oral pilocarpine to reduce hyposalivation and mucositis associated with radiation therapy in head and neck cancer patients","volume":"51","author":"Scarantino","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.seminoncol.2004.12.008_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0167-8140(01)00449-2","article-title":"Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma","volume":"61","author":"Chao","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1053\/j.seminoncol.2004.12.008_bib12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1146\/annurev.ph.57.030195.002555","article-title":"In defense of the oral cavity","volume":"57","author":"Tabak","year":"1995","journal-title":"Ann Rev Physiol"},{"key":"10.1053\/j.seminoncol.2004.12.008_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0360-3016(99)00247-3","article-title":"Dose, volume, and function relationships in parotid salivary glands following conformal and intensity modulated irradiation of head and neck cancer","volume":"45","author":"Eisbruch","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.seminoncol.2004.12.008_bib14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0360-3016(03)00093-2","article-title":"Dosimetric predictors for xerostomia for head and neck cancer patients treated with SMART (simultaneous modulated accelerated radiation therapy) boost technique","volume":"56","author":"Ammoson","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.seminoncol.2004.12.008_bib15","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1200\/JCO.2000.18.11.2226","article-title":"Subcutaneous administration of amifostine during fractionated radiotherapy","volume":"18","author":"Koukourakis","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2004.12.008_bib16","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0360-3016(01)02683-9","article-title":"Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head and neck cancer","volume":"52","author":"Antonadou","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009377540400627X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009377540400627X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T04:29:13Z","timestamp":1554352153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009377540400627X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":16,"alternative-id":["S009377540400627X"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2004.12.008","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}